Exelixis (EXEL) Other Accumulated Expenses (2010 - 2026)

Exelixis' (EXEL) quarterly Other Accumulated Expenses came in at $100.3 million in Q2 2026, down 20.12% year-on-year from $125.6 million in Q2 2025, and down 20.02% quarter-over-quarter from $125.4 million in Q1 2026.

Exelixis (EXEL) Other Accumulated Expenses (2010 - 2026) Analysis & Trends

Exelixis' Other Accumulated Expenses history runs 17 years deep, the most recent figure standing at $100.3 million for Q2 2026.

  • On a quarterly basis, Other Accumulated Expenses fell 20.12% year-over-year to $100.3 million in Q2 2026; TTM through Apr 2026 was $100.3 million, a 20.12% decrease from a year earlier, with the FY2026 full-year figure at $125.4 million, up 31.96% from the prior year.
  • Other Accumulated Expenses fell to $100.3 million in Q2 2026 per EXEL's latest filing, from $125.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $125.6 million in Q2 2025 and bottomed at $63.7 million in Q2 2022.
  • The 5-year median for Other Accumulated Expenses is $101.4 million (2025), against an average of $99.0 million.
  • Across the five-year window, Other Accumulated Expenses soared 55.39% in 2023 and retreated 23.1% in 2024, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $78.9 million in 2022, then surged by 37.37% to $108.4 million in 2023, then slipped by 11.71% to $95.7 million in 2024, then climbed by 9.3% to $104.6 million in 2025, then decreased by 4.14% to $100.3 million in 2026.
  • Per Business Quant, the three latest EXEL Other Accumulated Expenses figures stand at $100.3 million (Q2 2026), $125.4 million (Q1 2026), and $104.6 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,440.76 Bn 66,440.47 Bn -
2 Nanobiotix 1,909.20 Bn 1,909.14 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 468.28 Bn 463.49 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.49 Bn 115.24 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.26 Bn 61.51 Bn 3.31 Bn
7 Belite Bio 62.88 Bn 62.88 Bn -
8 Argenx Se 55.67 Bn 50.48 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn
10 Exelixis 14.47 Bn 13.69 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 100.29 Mn
Jan 2, 2026 125.38 Mn
Oct 3, 2025 104.62 Mn
Jul 4, 2025 101.37 Mn
Apr 4, 2025 125.55 Mn
Jan 3, 2025 95.01 Mn
Sep 27, 2024 95.72 Mn
Jun 28, 2024 103.24 Mn
Mar 29, 2024 104.29 Mn
Dec 29, 2023 108.42 Mn
Sep 29, 2023 124.48 Mn
Jun 30, 2023 110.70 Mn
Mar 31, 2023 89.49 Mn
Dec 30, 2022 78.92 Mn
Sep 30, 2022 80.11 Mn
Jul 1, 2022 72.57 Mn
Apr 1, 2022 63.65 Mn
Dec 31, 2021 53.37 Mn
Oct 1, 2021 54.75 Mn
Jul 2, 2021 63.85 Mn